News|Articles|August 5, 2024
Simplifying Manufacturing of Alphavirus Self-Amplifying RNA Replicons
Author(s)TriLink
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5